| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Metformin confers risk reduction for developing hepatocellular carcinoma recurrence after liver resection. | Liver Int | 2016 | 0.76 |
| 2 | Efficacy of External Beam Radiation-Based Treatment plus Locoregional Therapy for Hepatocellular Carcinoma Associated with Portal Vein Tumor Thrombosis. | Biomed Res Int | 2016 | 0.75 |